1. Home
  2. PBMWW vs GRABW Comparison

PBMWW vs GRABW Comparison

Compare PBMWW & GRABW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PBMWW
  • GRABW
  • Stock Information
  • Founded
  • PBMWW N/A
  • GRABW N/A
  • Country
  • PBMWW Canada
  • GRABW Singapore
  • Employees
  • PBMWW 10
  • GRABW 10604
  • Industry
  • PBMWW
  • GRABW Business Services
  • Sector
  • PBMWW
  • GRABW Consumer Discretionary
  • Exchange
  • PBMWW Nasdaq
  • GRABW Nasdaq
  • Market Cap
  • PBMWW N/A
  • GRABW N/A
  • IPO Year
  • PBMWW N/A
  • GRABW N/A
  • Fundamental
  • Price
  • PBMWW $0.01
  • GRABW $0.21
  • Analyst Decision
  • PBMWW
  • GRABW
  • Analyst Count
  • PBMWW 0
  • GRABW 0
  • Target Price
  • PBMWW N/A
  • GRABW N/A
  • AVG Volume (30 Days)
  • PBMWW N/A
  • GRABW N/A
  • Earning Date
  • PBMWW N/A
  • GRABW N/A
  • Dividend Yield
  • PBMWW N/A
  • GRABW N/A
  • EPS Growth
  • PBMWW N/A
  • GRABW N/A
  • EPS
  • PBMWW N/A
  • GRABW N/A
  • Revenue
  • PBMWW N/A
  • GRABW N/A
  • Revenue This Year
  • PBMWW N/A
  • GRABW N/A
  • Revenue Next Year
  • PBMWW N/A
  • GRABW N/A
  • P/E Ratio
  • PBMWW N/A
  • GRABW N/A
  • Revenue Growth
  • PBMWW N/A
  • GRABW N/A
  • 52 Week Low
  • PBMWW N/A
  • GRABW N/A
  • 52 Week High
  • PBMWW N/A
  • GRABW N/A
  • Technical
  • Relative Strength Index (RSI)
  • PBMWW N/A
  • GRABW 51.88
  • Support Level
  • PBMWW N/A
  • GRABW $0.21
  • Resistance Level
  • PBMWW N/A
  • GRABW $0.24
  • Average True Range (ATR)
  • PBMWW 0.00
  • GRABW 0.02
  • MACD
  • PBMWW 0.00
  • GRABW -0.00
  • Stochastic Oscillator
  • PBMWW 0.00
  • GRABW 23.89

About PBMWW Psyence Biomedical Ltd. Warrant

Psyence Biomedical Ltd is a life science biotechnology company pioneering the use of natural psychedelics in mental health and wellbeing. It develops natural psilocybin products for the healing of psychological trauma and its mental health consequences in the context of palliative care. The company has commenced the clinical trial process to evaluate the safety and efficacy of its product candidates. It cultivates natural psilocybin mushrooms at its federally licensed facility in Southern Africa. This product is produced for export to its partners across the world to be processed into a standardized encapsulated product.

About GRABW Grab Holdings Limited Warrant

Founded in 2012, Grab provides ride-sharing services, food and grocery delivery, and financial services (payments, consumer loans, and enterprise offerings) in eight Southeast-Asian countries through its mobile platform. The company partners with merchants and riders, connecting them with consumers while charging commission to both sides. Grab has a leading market share in and derives 89% of its revenue from its core businesses, ride-sharing and food delivery. Singapore and Malaysia contributed 58% of revenue as of end-2021. Grab's main competitors in Southeast Asia are Foodpanda and Gojek, the ride-sharing arm of GoTo. Its financial services business is still in its nascent stage and provides minimal revenue currently. The company now also generates advertising revenue.

Share on Social Networks: